Efficacy of Combined Initial Treatment of Methotrexate with Infliximab in Pediatric Crohn’s Disease: A Pilot Study

Background: The combination of antitumor necrosis factor-alpha (TNF-α) agents with immunomodulators (IMMs) is a common treatment for pediatric Crohn’s disease (CD). Although methotrexate (MTX) can be a first-line medication as an IMM, most clinicians in real-life practice, especially in South Korea,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yoon-Zi, Kang, Ben, Kim, Eun-Sil, Kwon, Yiyoung, Choe, Yon-Ho, Kim, Mi-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526834/
https://www.ncbi.nlm.nih.gov/pubmed/37761016
http://dx.doi.org/10.3390/biomedicines11092575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526834/
https://www.ncbi.nlm.nih.gov/pubmed/37761016
http://dx.doi.org/10.3390/biomedicines11092575

Ejemplares similares